2019 Compound Screening Small Molecule Treatment 
Drug Target Review
NOVEMBER 1, 2023
The mission of the CCDD is to discover novel small-molecule therapeutics for the treatment of cancer and progress them to hypothesis testing phase 1 clinical trials. We need to build the assays that we need for compound screening. Although we are an academic centre we work very much like industry.
Drug Discovery World
JANUARY 26, 2023
Research into HIV blossomed throughout 2022, with ViiV Healthcare’s combination therapy for HIV-1 gaining approval in Japan; and research moving forward towards a one-time treatment for HIV as well as a vaccine. In terms of activity, a number of large-scale acquisitions took place, with Pfizer’s purchase of Biohaven for $11.6
Expert insights. Personalized for you.
96 
Let's personalize your content